Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 1
1995 1
1996 2
1997 3
1998 4
1999 3
2000 2
2001 1
2002 6
2003 4
2004 9
2005 9
2006 4
2007 3
2008 5
2009 2
2010 11
2011 9
2012 15
2013 7
2014 7
2015 6
2016 4
2017 3
2018 1
2019 3
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for strumberg d
Search for Sturmberg D instead (1 results)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH; CASSINI Investigators. Khorana AA, et al. N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630. N Engl J Med. 2019. PMID: 30786186 Clinical Trial.
Regorafenib for cancer.
Strumberg D, Schultheis B. Strumberg D, et al. Expert Opin Investig Drugs. 2012 Jun;21(6):879-89. doi: 10.1517/13543784.2012.684752. Expert Opin Investig Drugs. 2012. PMID: 22577890 Review.
Sorafenib for the treatment of renal cancer.
Strumberg D. Strumberg D. Expert Opin Pharmacother. 2012 Feb;13(3):407-19. doi: 10.1517/14656566.2012.654776. Epub 2012 Jan 20. Expert Opin Pharmacother. 2012. PMID: 22263843 Review.
Raf kinase inhibitors in oncology.
Strumberg D, Seeber S. Strumberg D, et al. Onkologie. 2005 Feb;28(2):101-7. doi: 10.1159/000083373. Onkologie. 2005. PMID: 15665559 Review.
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM.
Goetze TO, Hofheinz RD, Gaiser T, Schmalenberg H, Strumberg D, Goekkurt E, Angermeier S, Zander T, Kopp HG, Pink D, Siegler G, Schenk M, de Vita F, Galizia G, Maiello E, Bechstein WO, Elshafei M, Loose M, Sookthai D, Brulin T, Pauligk C, Homann N, Al-Batran SE. Goetze TO, et al. Among authors: strumberg d. Int J Cancer. 2023 Jul 1;153(1):153-163. doi: 10.1002/ijc.34495. Epub 2023 Mar 23. Int J Cancer. 2023. PMID: 36883420 Clinical Trial.
[Metastases with CUP syndrome].
Seeber S, Strumberg D. Seeber S, et al. Among authors: strumberg d. Urologe A. 2006 May;45(5):614-9. doi: 10.1007/s00120-006-1054-2. Urologe A. 2006. PMID: 16710679 Review. German.
116 results